BLUEJET

Blue Jet Healthcare, a small-cap player in the pharmaceuticals and biotechnology sector. This change is attributed to a shift in technical trends from mildly bullish to sideways. The company's current stock price stands at Rs 762.55, down from a previous close of Rs 792.00, with a 52-week high of Rs 1,028.20 and a low of Rs 454.75. Despite the recent downgrade, Blue Jet Healthcare has demonstrated strong financial performance in the first quarter of FY25-26, with net sales growing at an annual rate of 27.13% and operating profit increasing by 42.32%. The company has reported positive results for four consecutive quarters, with a profit after tax of Rs 201.27 crore, reflecting a growth of 159.94%. With a market capitalization of Rs 13,228 crore, Blue Jet Healthcare is the second-largest company in its sector, accounting for 31.61% of the industry. The stock has outperformed the market over the past year, generating a return of 63.81%, significantly higher than the BSE500's return of 0.35%.